Found: 13
Select item for more details and to access through your institution.
Current and future advances in practice: a practical approach to the diagnosis and management of primary central nervous system vasculitis.
- Published in:
- Rheumatology Advances in Practice, 2023, v. 7, n. 3, p. 1, doi. 10.1093/rap/rkad080
- By:
- Publication type:
- Article
Transcranial Doppler ultrasound to evaluate the risk of hyperperfusion after endovascular stroke thrombectomy.
- Published in:
- Journal of Neuroimaging, 2024, v. 34, n. 1, p. 50, doi. 10.1111/jon.13168
- By:
- Publication type:
- Article
Chronic ischemic lesions and presence of patent foramen ovale in young adults with embolic stroke of undetermined source: Results of the young ESUS patient registry.
- Published in:
- International Journal of Stroke, 2024, v. 19, n. 4, p. 470, doi. 10.1177/17474930231217917
- By:
- Publication type:
- Article
Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: NAVIGATE ESUS MRI substudy.
- Published in:
- International Journal of Stroke, 2022, v. 17, n. 7, p. 799, doi. 10.1177/17474930211058012
- By:
- Publication type:
- Article
Embolic strokes of undetermined source: Prevalence and patient features in the ESUS Global Registry.
- Published in:
- International Journal of Stroke, 2016, v. 11, n. 5, p. 526, doi. 10.1177/1747493016641967
- By:
- Publication type:
- Article
What's new in stroke? Phase III randomized clinical trials of 2012-2014.
- Published in:
- International Journal of Stroke, 2015, v. 10, n. 6, p. 790, doi. 10.1111/ijs.12570
- By:
- Publication type:
- Article
In AF, apixaban reduced stroke or systemic embolism compared with warfarin, regardless of patient age.
- Published in:
- ACP Journal Club, 2014, v. 160, n. 12, p. 1
- By:
- Publication type:
- Article
In AF, apixaban reduced stroke or systemic embolism compared with warfarin, regardless of patient age.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Evaluating Rates of Recurrent Ischemic Stroke Among Young Adults With Embolic Stroke of Undetermined Source: The Young ESUS Longitudinal Cohort Study.
- Published in:
- JAMA Neurology, 2022, v. 79, n. 5, p. 450, doi. 10.1001/jamaneurol.2022.0048
- By:
- Publication type:
- Article
Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 10, p. 1233, doi. 10.1001/jamaneurol.2020.1995
- By:
- Publication type:
- Article
Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes: A Secondary Analysis of the COMPASS Trial.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 1, p. 43, doi. 10.1001/jamaneurol.2019.2984
- By:
- Publication type:
- Article
In AF, apixaban reduced stroke or systemic embolism compared with warfarin, regardless of patient age.
- Published in:
- 2014
- By:
- Publication type:
- Opinion
Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2019, v. 76, n. 7, p. 764, doi. 10.1001/jamaneurol.2019.0617
- By:
- Publication type:
- Article